During the last session, Guardant Health Inc (NASDAQ:GH)’s traded shares were 1.8 million, with the beta value of the company hitting 0.92. At the end of the trading day, the stock’s price was $18.10, reflecting an intraday gain of 4.38% or $0.76. The 52-week high for the GH share is $41.06, that puts it down -126.85 from that peak though still a striking 12.65% gain since the share price plummeted to a 52-week low of $15.81. The company’s market capitalization is $2.20B, and the average trade volume was 1.97 million shares over the past three months.
Guardant Health Inc (NASDAQ:GH) trade information
Guardant Health Inc (GH) registered a 4.38% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.38% in intraday trading to $18.10, hitting a weekly high. The stock’s 5-day price performance is 10.43%, and it has moved by 5.66% in 30 days. Based on these gigs, the overall price performance for the year is -21.54%.
Guardant Health Inc (GH) estimates and forecasts
Statistics show that Guardant Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Guardant Health Inc (GH) shares have gone down -30.33% during the last six months, with a year-to-date growth rate more than the industry average at 37.62% against 12.90. In the rating firms’ projections, revenue will increase 17.70% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 150.67M as predicted by 19 analyst(s). Meanwhile, a consensus of 18 analyst(s) estimates revenue growth to 160.9M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 128.71M and 137.15M respectively. In this case, analysts expect current quarter sales to grow by 17.10% and then jump by 17.30% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -8.88%. While earnings are projected to return 23.51% in 2024, the next five years will return 27.80% per annum.
GH Dividends
Guardant Health Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
